Docket
117th Congress · HOUSE BILLBILL

H.R. 2855 — Star Rating for Biosimilars Act

“To amend title XVIII of the Social Security Act to require the Secretary of Health and Human Services to add a new set of measures to the 5-star rating system under the Medicare Advantage program in order to encourage increased access to biosimilar biological products.”

Health
Introduced Apr 26, 2021
Last action Apr 27, 2021
Pipeline · Bill → Law
Step 1
Introduced
Apr 26, 2021
Step 2
Referred
Apr 27, 2021
E&C · Ways & Means
Step 3
Committee
Step 4
House floor
Step 5
Senate
Step 6
Resolve Changes
Step 7
Signed
SummaryNo summary available

No CRS summary available for this bill.

Provisions · 2 sectionsIntroduced in House
Timeline · 6 actions
Apr 27, 2021
Referred to the Subcommittee on Health.
Apr 26, 2021
Introduced in House
Apr 26, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Apr 26, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Apr 26, 2021
Referred to the Subcommittee on Health.
Apr 26, 2021
Referred to the Subcommittee on Social Security.